NTRK2 and neutropenia: Since agonism of BDNF-TrkB signaling supports regeneration of both the bone marrow and thymus following radiation injury, these data would support the therapeutic use of BDNF or 7,8-DHF for the treatment of radiation-induced neutropenia and lymphocytopenia.